The beneficial effects of oral supplementation of SIRT1 activator-resveratrol (RSV) have been reported in AMD patients [59]; this is similar to the results obtained from a recent clinical trial on Alzheimer’s disease [60]. Here, SIRT1 is linked to age-related macular degeneration.